These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4865249)

  • 1. [Effects of prednisolone, periston-N and antitoxic serum on the absorption and localization of I-131-labelled Clostridium botulinum B toxin in guinea pigs].
    Stempień R; Fabianowski J; Ubysz-Jerzmanowska K; Brühl A
    Pol Tyg Lek; 1967 May; 22(18):665-8. PubMed ID: 4865249
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the effect of botulin toxin B on tissue respiration in the brain in guinea pigs].
    PAK ZP
    Farmakol Toksikol; 1959; 22():473-6. PubMed ID: 14429849
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum.
    Iida H; Ono T; Karashimada T
    Jpn J Med Sci Biol; 1970 Oct; 23(5):344-7. PubMed ID: 4993667
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological difference between the toxin of a progeolytic strain and that of a nonproteolytic strain of Clostridium botulinum type B.
    Shimizu T; Kondo H
    Jpn J Med Sci Biol; 1973 Dec; 26(5):269-71. PubMed ID: 4601358
    [No Abstract]   [Full Text] [Related]  

  • 5. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 6. [SENSITIVITY OF LABORATORY ANIMALS TO BOTULINUM TOXIN, TYPE C].
    MIERZEJEWSKI J
    Przegl Epidemiol; 1964; 18():77-84. PubMed ID: 14189171
    [No Abstract]   [Full Text] [Related]  

  • 7. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF THE TOXIN OF CLOSTRIDIUM BOTULINUM. 8. PROCEDURE FOR RAPID DIAGNOSIS OF BOTULINUM INTOXICATION AND ESTABLISHMENT OF THE TYPE OF OFFENDING TOXIN.
    BOROFF DA; FLECK U
    Int Arch Allergy Appl Immunol; 1965; 27():1-5. PubMed ID: 14296892
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on strain 84 of Clostridium botulinum.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig; 1970; 215(2):212-20. PubMed ID: 4992024
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 12. Another type of Clostridium botulinum.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig; 1970; 215(2):221-4. PubMed ID: 4922309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on Clostridium botulinum type E. VI. Binding power of the type E of botulinum toxin].
    Albrycht H; Rymkiewicz D; Meisel H
    Med Dosw Mikrobiol; 1965; 17(4):299-304. PubMed ID: 5326420
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.
    FIOCK MA; YARINSKY A; DUFF JT
    J Bacteriol; 1961 Jul; 82(1):66-71. PubMed ID: 13699727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the serum therapy of type E botulism: absorption of toxin from the gastrointestinal tract.
    Iida H; Ono T; Karashimada T; Ando Y
    Jpn J Med Sci Biol; 1970 Aug; 23(4):282-5. PubMed ID: 4992617
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological heterogeneity of Clostridium botulinum type B toxins.
    Shimizu T; Kondo H; Sakaguchi G
    Jpn J Med Sci Biol; 1974 Apr; 27(2):99-100. PubMed ID: 4134872
    [No Abstract]   [Full Text] [Related]  

  • 18. Supersensitivity of skeletal muscle produced by botulinum toxin.
    THESLEFF S
    J Physiol; 1960 Jun; 151(3):598-607. PubMed ID: 13837723
    [No Abstract]   [Full Text] [Related]  

  • 19. Phagocytosis of staphylococci by mouse leukocytes in the presence of botulinum toxin.
    FREEMAN NL
    J Bacteriol; 1961 Jan; 81(1):156-7. PubMed ID: 13701643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of type B botulinus toxin on the level of pyruvic acid in the tissues of guinea pigs].
    PAK ZP
    Farmakol Toksikol; 1962; 25():614-8. PubMed ID: 13941137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.